BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bahne E, Sun EWL, Young RL, Hansen M, Sonne DP, Hansen JS, Rohde U, Liou AP, Jackson ML, de Fontgalland D, Rabbitt P, Hollington P, Sposato L, Due S, Wattchow DA, Rehfeld JF, Holst JJ, Keating DJ, Vilsbøll T, Knop FK. Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes. JCI Insight 2018;3:93936. [PMID: 30518693 DOI: 10.1172/jci.insight.93936] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Tsuchida H, Morita Y, Nogami M, Ogawa W. Metformin action in the gut―insight provided by [18F]FDG PET imaging. Diabetol Int 2022;13:35-40. [DOI: 10.1007/s13340-021-00545-y] [Reference Citation Analysis]
2 Foretz M, Guigas B, Viollet B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol 2019;15:569-89. [DOI: 10.1038/s41574-019-0242-2] [Cited by in Crossref: 122] [Cited by in F6Publishing: 116] [Article Influence: 40.7] [Reference Citation Analysis]
3 Cravalho CKL, Meyers AG, Mabundo LS, Courville A, Yang S, Cai H, Dai Y, Walter M, Walter PJ, Sharma S, Chacko S, Cogen F, Magge SN, Haymond MW, Chung ST. Metformin improves blood glucose by increasing incretins independent of changes in gluconeogenesis in youth with type 2 diabetes. Diabetologia 2020;63:2194-204. [PMID: 32728891 DOI: 10.1007/s00125-020-05236-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mohammed I, Hollenberg MD, Ding H, Triggle CR. A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan. Front Endocrinol (Lausanne) 2021;12:718942. [PMID: 34421827 DOI: 10.3389/fendo.2021.718942] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Delavallée L, Mathiah N, Cabon L, Mazeraud A, Brunelle-Navas MN, Lerner LK, Tannoury M, Prola A, Moreno-Loshuertos R, Baritaud M, Vela L, Garbin K, Garnier D, Lemaire C, Langa-Vives F, Cohen-Salmon M, Fernández-Silva P, Chrétien F, Migeotte I, Susin SA. Mitochondrial AIF loss causes metabolic reprogramming, caspase-independent cell death blockade, embryonic lethality, and perinatal hydrocephalus. Mol Metab 2020;40:101027. [PMID: 32480041 DOI: 10.1016/j.molmet.2020.101027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
6 Bravard A, Gérard C, Defois C, Benoit B, Makki K, Meugnier E, Rainteau D, Rieusset J, Godet M, Vidal H. Metformin treatment for 8 days impacts multiple intestinal parameters in high-fat high-sucrose fed mice. Sci Rep 2021;11:16684. [PMID: 34404817 DOI: 10.1038/s41598-021-95117-0] [Reference Citation Analysis]
7 Wang L, Cai Y, Jian L, Cheung CW, Zhang L, Xia Z. Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy. Cardiovasc Diabetol 2021;20:2. [PMID: 33397369 DOI: 10.1186/s12933-020-01188-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Borg MJ, Xie C, Rayner CK, Horowitz M, Jones KL, Wu T. Potential for Gut Peptide-Based Therapy in Postprandial Hypotension. Nutrients 2021;13:2826. [PMID: 34444986 DOI: 10.3390/nu13082826] [Reference Citation Analysis]
9 Jones LA, Sun EW, Martin AM, Keating DJ. The ever-changing roles of serotonin. Int J Biochem Cell Biol 2020;125:105776. [PMID: 32479926 DOI: 10.1016/j.biocel.2020.105776] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
10 Kang Z, Zeng J, Zhang T, Lin S, Gao J, Jiang C, Fan R, Yin D. Hyperglycemia induces NF-κB activation and MCP-1 expression via downregulating GLP-1R expression in rat mesangial cells: inhibition by metformin. Cell Biol Int 2019;43:940-53. [PMID: 31136032 DOI: 10.1002/cbin.11184] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
11 Gasbjerg LS, Bari EJ, Christensen M, Knop FK. Exendin(9-39)NH2 : Recommendations for clinical use based on a systematic literature review. Diabetes Obes Metab 2021. [PMID: 34351033 DOI: 10.1111/dom.14507] [Reference Citation Analysis]
12 Sansome DJ, Xie C, Veedfald S, Horowitz M, Rayner CK, Wu T. Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids. Diabetes Obes Metab 2020;22:141-8. [PMID: 31468642 DOI: 10.1111/dom.13869] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
13 Deacon CF. Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus. Nat Rev Endocrinol 2020;16:642-53. [PMID: 32929230 DOI: 10.1038/s41574-020-0399-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
14 Mulla CM, Baloch HM, Hafida S. Management of Diabetes in Patients Undergoing Bariatric Surgery. Curr Diab Rep 2019;19:112. [PMID: 31686263 DOI: 10.1007/s11892-019-1242-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
15 Milardi D, Gazit E, Radford SE, Xu Y, Gallardo RU, Caflisch A, Westermark GT, Westermark P, Rosa C, Ramamoorthy A. Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes. Chem Rev 2021;121:1845-93. [PMID: 33427465 DOI: 10.1021/acs.chemrev.0c00981] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
16 Grøndahl MFG, Johannesen J, Kristensen K, Knop FK. Treatment of type 2 diabetes in children: what are the specific considerations? Expert Opin Pharmacother 2021;22:2127-41. [PMID: 34420454 DOI: 10.1080/14656566.2021.1954160] [Reference Citation Analysis]
17 Masson W, Lavalle-Cobo A, Lobo M, Masson G, Molinero G. Novel antidiabetic drugs and risk of cardiovascular events in patients without baseline metformin use: a meta-analysis. Eur J Prev Cardiol 2021;28:69-75. [PMID: 33606884 DOI: 10.1093/eurjpc/zwaa074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
18 Kuhre RE, Deacon CF, Holst JJ, Petersen N. What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell? Front Endocrinol (Lausanne) 2021;12:694284. [PMID: 34168620 DOI: 10.3389/fendo.2021.694284] [Reference Citation Analysis]
19 O'Neill P, Leung MST, Visser RAB, Harky A. Diabetic Control Agents and Their Impact on Cardiac Surgery Patients: A Clinical Overview. J Cardiovasc Pharmacol Ther 2021;26:225-32. [PMID: 33226267 DOI: 10.1177/1074248420963688] [Reference Citation Analysis]
20 Roy A, Sahoo J. Long-term effects of metformin use in gestational diabetes mellitus on offspring health. World J Diabetes 2021; 12(11): 1812-1817 [PMID: 34888009 DOI: 10.4239/wjd.v12.i11.1812] [Reference Citation Analysis]
21 Xie C, Huang W, Young RL, Jones KL, Horowitz M, Rayner CK, Wu T. Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease. Nutrients 2021;13:1104. [PMID: 33800566 DOI: 10.3390/nu13041104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
22 Dik B, Coşkun D, Bahçivan E, Üney K. Potential antidiabetic activity of benzimidazole derivative albendazole and lansoprazole drugs in different doses in experimental type 2 diabetic rats. Turk J Med Sci 2021;51:1579-86. [PMID: 33641315 DOI: 10.3906/sag-2004-38] [Reference Citation Analysis]
23 Bhansali S, Bhansali A, Dutta P, Walia R, Dhawan V. Metformin upregulates mitophagy in patients with T2DM: A randomized placebo-controlled study. J Cell Mol Med 2020;24:2832-46. [PMID: 31975558 DOI: 10.1111/jcmm.14834] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
24 Helsted MM, Gasbjerg LS, Lanng AR, Bergmann NC, Stensen S, Hartmann B, Christensen MB, Holst JJ, Vilsbøll T, Rosenkilde MM, Knop FK. The role of endogenous GIP and GLP-1 in postprandial bone homeostasis. Bone 2020;140:115553. [DOI: 10.1016/j.bone.2020.115553] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
25 Zajda A, Huttunen KM, Sikora J, Podsiedlik M, Markowicz-piasecka M. Is metformin a geroprotector? A peek into the current clinical and experimental data. Mechanisms of Ageing and Development 2020;191:111350. [DOI: 10.1016/j.mad.2020.111350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Martin AM, Sun EW, Rogers GB, Keating DJ. The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release. Front Physiol 2019;10:428. [PMID: 31057420 DOI: 10.3389/fphys.2019.00428] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 23.0] [Reference Citation Analysis]
27 Osonoi T, Tamasawa A, Osonoi Y, Ofuchi K, Katoh M, Saito M. Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study. Diabetes Ther 2019;10:2045-59. [PMID: 31506889 DOI: 10.1007/s13300-019-00689-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Panfoli I, Puddu A, Bertola N, Ravera S, Maggi D. The Hormetic Effect of Metformin: "Less Is More"? Int J Mol Sci 2021;22:6297. [PMID: 34208371 DOI: 10.3390/ijms22126297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Borg MJ, Rayner CK, Jones KL, Horowitz M, Xie C, Wu T. Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin. Pharmaceuticals (Basel) 2020;13:E410. [PMID: 33266396 DOI: 10.3390/ph13110410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Benedetti R, Benincasa G, Glass K, Chianese U, Vietri MT, Congi R, Altucci L, Napoli C. Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients: a meta-analysis of randomized clinical trials. Pharmacol Res 2021;175:106039. [PMID: 34929299 DOI: 10.1016/j.phrs.2021.106039] [Reference Citation Analysis]
31 Sari C, Seip RL, Umashanker D. Case Report: Off Label Utilization of Topiramate and Metformin in Patients With BMI ≥50 kg/m2 Prior to Bariatric Surgery. Front Endocrinol (Lausanne) 2021;12:588016. [PMID: 33716960 DOI: 10.3389/fendo.2021.588016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Lynn MA, Eden G, Ryan FJ, Bensalem J, Wang X, Blake SJ, Choo JM, Chern YT, Sribnaia A, James J, Benson SC, Sandeman L, Xie J, Hassiotis S, Sun EW, Martin AM, Keller MD, Keating DJ, Sargeant TJ, Proud CG, Wesselingh SL, Rogers GB, Lynn DJ. The composition of the gut microbiota following early-life antibiotic exposure affects host health and longevity in later life. Cell Rep 2021;36:109564. [PMID: 34433065 DOI: 10.1016/j.celrep.2021.109564] [Reference Citation Analysis]
33 Rosendo-Silva D, Matafome P. Gut-adipose tissue crosstalk: A bridge to novel therapeutic targets in metabolic syndrome? Obes Rev 2021;22:e13130. [PMID: 32815267 DOI: 10.1111/obr.13130] [Reference Citation Analysis]
34 Glossmann HH, Lutz OMD. Pharmacology of metformin - An update. Eur J Pharmacol 2019;865:172782. [PMID: 31705902 DOI: 10.1016/j.ejphar.2019.172782] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
35 Coll AP, Chen M, Taskar P, Rimmington D, Patel S, Tadross JA, Cimino I, Yang M, Welsh P, Virtue S, Goldspink DA, Miedzybrodzka EL, Konopka AR, Esponda RR, Huang JT, Tung YCL, Rodriguez-Cuenca S, Tomaz RA, Harding HP, Melvin A, Yeo GSH, Preiss D, Vidal-Puig A, Vallier L, Nair KS, Wareham NJ, Ron D, Gribble FM, Reimann F, Sattar N, Savage DB, Allan BB, O'Rahilly S. GDF15 mediates the effects of metformin on body weight and energy balance. Nature 2020;578:444-8. [PMID: 31875646 DOI: 10.1038/s41586-019-1911-y] [Cited by in Crossref: 112] [Cited by in F6Publishing: 110] [Article Influence: 37.3] [Reference Citation Analysis]
36 Wang L, Li Y, Guo B, Zhang J, Zhu B, Li H, Ding Y, Meng B, Zhao H, Xiang L, Dong J, Liu M, Zhang J, Xiang L, Xiang G. Myeloid-Derived Growth Factor Promotes Intestinal Glucagon-Like Peptide-1 Production in Male Mice With Type 2 Diabetes. Endocrinology 2020;161:bqaa003. [PMID: 31913472 DOI: 10.1210/endocr/bqaa003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
37 Sun EW, Matusica D, Wattchow DA, McCluskey A, Robinson PJ, Keating DJ. Dynamin regulates L cell secretion in human gut. Mol Cell Endocrinol 2021;535:111398. [PMID: 34274446 DOI: 10.1016/j.mce.2021.111398] [Reference Citation Analysis]
38 Sarnobat D, Moffett RC, Flatt PR, Tarasov AI. Effects of first-line diabetes therapy with biguanides, sulphonylurea and thiazolidinediones on the differentiation, proliferation and apoptosis of islet cell populations. J Endocrinol Invest 2021. [PMID: 34191257 DOI: 10.1007/s40618-021-01620-6] [Reference Citation Analysis]
39 Bora V, Patel BM. Investigation into the role of anti-diabetic agents in cachexia associated with metastatic cancer. Life Sci 2021;274:119329. [PMID: 33711389 DOI: 10.1016/j.lfs.2021.119329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]